Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Industry Looking For Details As Legislation Looks Likely On Hemp Ingredients' Use In Supplements

Jun 01 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Doubts Hemp ‘Derivatives Created From Scratch’ Belong In Lawful Use Pathway

Feb 06 2023

Is US Hemp Policy Heading For Farm Bill, Act III?

Jan 27 2023

FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps

Apr 03 2019

House Appropriations Subcommittee Proposes FDA FY2024 Budget $662M Short Of Request

May 23 2023

US Hemp Industry Group Rings Alarm With Congress About FDA’s Safety Conclusions

May 31 2023

Details Dished On Regulatory Pathway US FDA’s Developing For Lawful Hemp In Supplements

May 31 2023

Additional Topics

International United States US States Cannabidiol CBD FDA Politics Advertising, Marketing & Sales Business Strategies Commercial Compliance Consumer Dietary Supplements E-Commerce Enforcement Ingredients Legal Issues Legislation Lobbying Manufacturing Policy Regulation Retail

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window